(Circulation. 1999;99:2669-2676.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
Long-Term Survival and Valve-Related Complications in Young Women With Cardiac Valve Replacements
From the Department of Obstetrics and Gynaecology, University of Auckland (R.A.N., L.S., L.M.E.M.); the Department of Community Health, University of Auckland (A.W.S.); and the Departments of Cardiology (H.D.W.) and Cardiothoracic Surgery (A.R.K.), Green Lane Hospital, Auckland, New Zealand.
Correspondence to Dr Robyn North, Department of Obstetrics and Gynaecology, National Women's Hospital, Claude Rd, Private Bag 92 189, Auckland 1030, New Zealand. E-mail r.north{at}auckland.ac.nz
Background—The type of cardiac valve replacement associated with the lowest health risks for young women who may undergo pregnancies is unknown. We investigated which valve type was associated with greatest patient and valve survival and the effect of pregnancy on valve loss.
Methods and Results—In this retrospective study, all women 12 to 35 years old who underwent valve replacements between 1972 and 1992 at Greenlane Hospital were identified, and follow-up was available in 93%. The 232 women were followed up for 1499 patient-years. Ten-year survival of women with mechanical (n=178), bioprosthetic (n=73), and homograft (n=72) valves was 70% (95% CI, 59% to 83%), 84% (95% CI, 72% to 99%), and 96% (95% CI, 91% to 100%), P=0.002. After adjustment for confounding variables, the relative risk (RR) of death with mechanical compared with bioprosthetic valves was 2.17 (95% CI, 0.78 to 5.88). Thromboembolic events occurred in 45% of women with mechanical valves within 5 years, compared with 13% with bioprosthetic valves, P=0.0001. Valve loss at 10 years was higher in bioprosthetic valves [82% (95% CI, 62% to 92%)] than in mechanical [29% (95% CI, 17% to 39%)] or homograft [28% (95% CI, 12% to 41%)] valves, P=0.0001. Pregnancy was not associated with increased bioprosthetic (RR, 0.96; 95% CI, 0.68 to 1.35), homograft (RR, 0.65; 95% CI, 0.37 to 1.13), or mechanical (RR, 0.54; 95% CI, 0.27 to 1.08) valve loss.
Conclusions—Although 10-year valve survival was greater with mechanical than bioprosthetic valves, mechanical valves may be associated with reduced patient survival in young women. Thromboembolic complications, often with long-term sequelae, were common with mechanical valves. Pregnancy did not increase structural deterioration or reduce survival of bioprosthetic valves.
Key Words: valves • women • pregnancy
This article has been cited by other articles:
 |
|
 |
|
  F. M. Jeejeebhoy Prosthetic heart valves and management during pregnancy Can Fam Physician, February 1, 2009; 55(2): 155 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P Akhtar, A. R Abid, H. Zafar, M. A Cheema, and J. S Khan Anticoagulation in Pregnancy with Mechanical Heart Valves: 10-Year Experience Asian Cardiovasc Thorac Ann, December 1, 2007; 15(6): 497 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. B. Luciani, A. Favaro, G. Casali, F. Santini, and A. Mazzucco Ross Operation in the Young: A Ten-Year Experience Ann. Thorac. Surg., December 1, 2005; 80(6): 2271 - 2277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Elkayam and F. Bitar Valvular Heart Disease and Pregnancy: Part II: Prosthetic Valves J. Am. Coll. Cardiol., August 2, 2005; 46(3): 403 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ali, B. Iung, E. Lansac, P. Bruneval, and C. Acar Homograft replacement of the mitral valve: Eight-year results J. Thorac. Cardiovasc. Surg., October 1, 2004; 128(4): 529 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ray, G. J. Murphy, and L. E. Shutt Recognition and management of maternal cardiac disease in pregnancy Br. J. Anaesth., September 1, 2004; 93(3): 428 - 439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Reimold and J. D. Rutherford Valvular Heart Disease in Pregnancy N. Engl. J. Med., July 3, 2003; 349(1): 52 - 59. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cebotari, H. Mertsching, K. Kallenbach, S. Kostin, O. Repin, A. Batrinac, C. Kleczka, A. Ciubotaru, and A. Haverich Construction of Autologous Human Heart Valves Based on an Acellular Allograft Matrix Circulation, September 24, 2002; 106(12_suppl_1): I-63 - I-68. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Grown-up congenital heart (GUCH) disease: current needs and provision of service for adolescents and adults with congenital heart disease in the UK Heart, September 1, 2002; 88(90001): i1 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Gopal, I. M. Hudson, J. Ludmir, M. N. Braffman, S. Ewing, J. E. Bavaria, K.-L. Wong, and C. R. Bridges Homograft aortic root replacement during pregnancy Ann. Thorac. Surg., July 1, 2002; 74(1): 243 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bloomfield Choice of heart valve prosthesis Heart, June 1, 2002; 87(6): 583 - 589. [Full Text] [PDF]
|
|
|
|
|
|
S. S Kabbani Is it Time to Look for an Alternative? Asian Cardiovasc Thorac Ann, June 1, 2001; 9(2): 79 - 81. [Full Text] [PDF]
|
|
|
|
|
|
S. C Siu and J. M Colman CONGENITAL HEART DISEASE: Heart disease and pregnancy Heart, June 1, 2001; 85(6): 710 - 715. [Full Text]
|
|
|
|
|
|
J. J. Collins Risks of Valve Replacements in Young Women Circulation, May 25, 1999; 99(20): 2613 - 2613. [Full Text] [PDF]
|
|